Australian Foundation Investment Company Limited (AFI)

NZX-listed Financials company — share price, dividends, financials, board of directors and governance score.

Australian Foundation Investment Company Limited (NZX:AFI) last traded at $8.20 on 22 Oct 2026, a market capitalisation of $10.35B NZD, a board of 8 directors chaired by Craig Drummond and a Governance Risk Score of 92/100.

AFT Pharmaceuticals develops, manufactures, and markets pharmaceutical products including pain management, eye care, and consumer healthcare products sold in over 100 countries globally.

Share price
$8.20+0.85%
Market cap
$10.35BNZD
P/E ratio
13.3
Return on equity
3.3%
Governance score
92/100Excellent
Board size
8directors
Last dividend
9.25cFY2026

Loading issuer details...

How Australian Foundation Investment Company Limited makes money — FY2025

Revenue $328.1m · Net profit $285.0m (86.8% of revenue)

Australian Foundation Investment Company Limited (AFI) FY2025: where revenue of $328.1m wentRevenue → EBIT: $307.4mRevenue → Operating expenses (incl. depreciation): $20.7mEBIT → Net profit: $285.0mEBIT → Interest: $1.2mEBIT → Income tax: $21.3mRevenue: $328.1mRevenue$328.1mEBIT: $307.4mEBIT$307.4mOperating expenses (incl. depreciation): $20.7mOperating expenses(incl. depreciation)$20.7mNet profit: $285.0mNet profit$285.0mInterest: $1.2mInterest$1.2mIncome tax: $21.3mIncome tax$21.3m

Band widths are proportional to NZD amounts. Dashed outlines mark derived figures; the hatched node is a balancing item (net profit less every line above it).

Australian Foundation Investment Company Limited FY2025 figures used in the chart
FY2025AmountStatusNote
Revenue$328.1mReported
Operating expenses (incl. depreciation)−$20.7mReported
Depreciation & amortisation—Not reported
EBIT$307.4mReported
Interest (net finance costs)−$1.2mReported
Income tax−$21.3mReported
Other items (net gain)+$0Balancing item *Net profit less the lines above; covers fair-value movements, impairments, associates and anything else not itemised.
Net profit$285.0mReported

Figures extracted automatically from the annual report; check against the report. NZD thousands as stored, shown in millions. Source: annual_report_pdf · method: claude_haiku_pdf · extracted 7 March 2026.

Annual report: Australian Foundation Investment Company Limited Annual Report (PDF, NZX)

Every charted year for AFI, with checks

Australian Foundation Investment Company Limited board of directors

8 current directors, average tenure 5.1 years.

DirectorRoleIndependentAppointedTenureCommittees
Craig DrummondChairYes20233.1 yrsNomination Committee (Chair), Remuneration Committee (Chair), Audit & Risk Committee
Tom PalmerDirectorNot recorded20260.0 yrs—
Graeme LiebeltIndependent DirectorYes201214.4 yrsAudit & Risk Committee
Julie FaheyIndependent DirectorYes20215.5 yrsNomination Committee (Chair), Remuneration Committee (Chair), Audit & Risk Committee (Chair)
Not provided in extracted textNon-Independent DirectorNo———
Rebecca Dee-BradburyIndependent DirectorYes20197.5 yrsRemuneration Committee, Nomination Committee (Chair), Audit & Risk Committee (Chair)
Richard MurrayIndependent DirectorYes20242.8 yrsAudit & Risk Committee, Nomination Committee
Katie HudsonIndependent DirectorYes20242.8 yrsAudit & Risk Committee, Nomination Committee

AFI governance score breakdown

Australian Foundation Investment Company Limited scores 92/100 (Excellent) on the NZXplorer Governance Risk Score for FY2026, based on 73% data coverage. See the GRS methodology.

Board structure
25/25
Shareholder rights
20/20
Executive remuneration
6.5/10

AFI dividends

The most recent Australian Foundation Investment Company Limited dividend on record is 9.25 cents per share, for FY2026 (interim), ex-dividend 15 Oct 2026, paid 12 Nov 2026.

Australian Foundation Investment Company Limited largest shareholders

Top 10 registered holders of AFI as disclosed for FY2025. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.

#HolderHolding
1HSBC Custody Nominees (Australia) Limited3.31%
2Evanson Pty Ltd1.52%
3Citicorp Nominees Pty Limited1.22%
4Netwealth Investments Limited <Wrap Services A/C>1.02%
5BNP Paribas Nominees Pty Ltd <HUB24 Custodial Serv Ltd>0.71%
6IOOF Investment Services Limited <IPS Superfund A/C>0.57%
7IOOF Investment Services Limited <IOOF idps A/C>0.46%
8HMS Nominees Ltd0.38%
9Netwealth Investments Limited <Super Services A/C>0.36%
10Custodial Services Limited <Beneficiaries Holding A/C>0.27%

Recent AFI NZX announcements

The 10 most recent filings by Australian Foundation Investment Company Limited to the NZX.

Australian Foundation Investment Company Limited (AFI) — frequently asked questions

What does Australian Foundation Investment Company Limited do?

AFT Pharmaceuticals develops, manufactures, and markets pharmaceutical products including pain management, eye care, and consumer healthcare products sold in over 100 countries globally. Australian Foundation Investment Company Limited is listed on the NZX under the ticker AFI, in the Financials sector.

What is the Australian Foundation Investment Company Limited (AFI) share price?

Australian Foundation Investment Company Limited (NZX:AFI) shares closed at $8.20 on 22 October 2026, up 0.85% on the previous close. At that price its market capitalisation was about $10.33 billion, based on 1,259,418,258 shares on issue as at 25 February 2026.

Who are the directors of Australian Foundation Investment Company Limited?

Australian Foundation Investment Company Limited has 8 current directors: Craig Drummond (Chair), Tom Palmer (Director), Graeme Liebelt (Independent Director), Julie Fahey (Independent Director), Not provided in extracted text (Non-Independent Director), Rebecca Dee-Bradbury (Independent Director), Richard Murray (Independent Director) and Katie Hudson (Independent Director).

Who is the chair of Australian Foundation Investment Company Limited?

Craig Drummond chairs the Australian Foundation Investment Company Limited board, and has been a director since 2023.

Who is the CEO of Australian Foundation Investment Company Limited?

Mark Freeman is the Managing Director / Chief Executive Officer of Australian Foundation Investment Company Limited.

What was Australian Foundation Investment Company Limited's most recent dividend?

The most recent Australian Foundation Investment Company Limited dividend on record is 9.25 cents per share for FY2026 (interim), ex-dividend 15 October 2026, paid 12 November 2026.

Who are the largest shareholders of Australian Foundation Investment Company Limited?

The largest registered holder of AFI shares in the FY2025 top-20 register was HSBC Custody Nominees (Australia) Limited, with 3.31%, followed by Evanson Pty Ltd (1.52%) and Citicorp Nominees Pty Limited (1.22%). Custodians and nominees on the register hold shares on behalf of other investors.

What is Australian Foundation Investment Company Limited's governance score?

Australian Foundation Investment Company Limited has an NZXplorer Governance Risk Score of 92/100 (Excellent) for FY2026, based on 73% data coverage.

When was the last Australian Foundation Investment Company Limited annual meeting?

The most recent Australian Foundation Investment Company Limited annual meeting on record was held on 1 October 2026.

Financials companies on the NZX

Compare Australian Foundation Investment Company Limited with other NZX-listed financials companies.

All NZX Financials companies · All NZX-listed companies